Autumn Glory Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-660
Closed -$268K – 202
2025
Q2
$268K Hold
660
– – 0.13% 155
2025
Q1
$328K Hold
660
– – 0.16% 131
2024
Q4
$343K Sell
660
-707
-52% -$389K 0.17% 120
2024
Q3
$846K Buy
1,367
+707
+107% +$419K 0.33% 87
2024
Q2
$365K Hold
660
– – 0.19% 111
2024
Q1
$384K Hold
660
– – 0.19% 107
2023
Q4
$358K Hold
660
– – 0.2% 109
2023
Q3
$334K Hold
660
– – 0.2% 107
2023
Q2
$344K Buy
+660
New +$356K 0.25% 94
2023
Q1
– Sell
-1,200
Closed -$661K – 178
2022
Q4
$661K Buy
1,200
+600
+100% +$318K 0.35% 87
2022
Q3
$304K Sell
600
-52
-8% -$29.1K 0.2% 107
2022
Q2
$354K Buy
+652
New +$359K 0.26% 93
2022
Q1
– Sell
-1,594
Closed -$1.06M – 219
2021
Q4
$1.06M Buy
+1,594
New +$995K 0.44% 61

Other funds holding TMO

Autumn Glory Partners's TMO Position: Q3 2025 in Review

Autumn Glory Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 660 shares — an estimated $268K sold.

Autumn Glory Partners first reported a position in TMO in Q4 2021 and held it in 13 quarters. The position peaked at $1.06M in Q4 2021. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Autumn Glory Partners reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Autumn Glory Partners sold 660 Thermo Fisher Scientific shares in Q3 2025, an estimated $268K.
  • Autumn Glory Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 13 quarters.
  • Autumn Glory Partners's Thermo Fisher Scientific position peaked at $1.06M in Q4 2021.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Autumn Glory Partners's 13F filing for Q3 2025, filed 22 Oct 2025.